CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Previously Reported [Member]	Convertible Preferred Stock	Convertible Preferred Stock Previously Reported [Member]	Series C Preferred Stock	Common Stock	Common Stock Previously Reported [Member]	Additional Paid-in Capital	Additional Paid-in Capital Previously Reported [Member]	Accumulated Deficit	Accumulated Deficit Previously Reported [Member]	Accumulated other comprehensive income
Balance at the beginning at Dec. 31, 2019	$ (44,429)	$ (44,429)						$ 1,104	$ 1,104	$ (45,533)	$ (45,533)
Balance (in Shares) at Dec. 31, 2019			74,159,000	15,181,000
Balance at the beginning at Dec. 31, 2019			$ 46,206	$ 46,206
Balance (in Shares) at Dec. 31, 2019						4,865,000	996,000
Retroactive application of exchange ratio, Shares at Dec. 31, 2019				58,978,000			3,869,000
Stock-based compensation	1,759							1,759
Stock-based compensation (in Shares)						4,123,000
Issuance of Series C Preferred Stock for cash, net of offering costs			$ 57,439
Issuance of Series C Preferred Stock for cash, net of offering costs (in Shares)			26,946,000
Conversion of Convertible Note to Series C-1 Preferred Stock			$ 7,787
Conversion of Convertible Note to Series C-1 Preferred Stock (in Shares)			3,717,000
Issuance of common stock in connection with acquisition	813							813
Issuance of common stock in connection with acquisition (in Shares)						1,373,000
Common stock warrants related to marketing expense	481							481
Exercise of warrants (in Shares)						15,000
Net loss	(37,109)									(37,109)
Other comprehensive loss	235											$ 235
Balance at Dec. 31, 2020	$ (78,250)							4,157		(82,642)		235
Balance (in Shares) at Dec. 31, 2020	104,822		104,822,000
Balance at the end at Dec. 31, 2020	$ 111,432		$ 111,432
Balance (in Shares) at Dec. 31, 2020						10,376,000
Conversion of Convertible Preferred Stock to Common Stock	146,225		$ (146,225)			$ 13		146,212
Conversion of Convertible Preferred Stock to Common Stock, shares			(121,226,000)			121,226,000
Reverse recapitalization, net of transaction costs	444,647					$ 6		444,641
Reverse recapitalization, net of transaction costs, Shares						59,657,000
Stock-based compensation	8,131							8,131
Redemption of warrants, Shares						148,000
Issuance of Series C Convertible Preferred Stock (in Shares)					16,404,000
Issuance of Series C Convertible Preferred Stock					$ 34,793
Common stock warrants issued to customers as consideration	121							121
Common stock warrants related to marketing expense	810							810
Exercise of warrants	5							5
Exercise of warrants (in Shares)						2,457,000
Net loss	(71,961)									(71,961)
Other comprehensive loss	(226)											(226)
Balance at Dec. 31, 2021	$ 449,502					$ 19		$ 604,077		$ (154,603)		$ 9
Balance (in Shares) at Dec. 31, 2021	0
Balance (in Shares) at Dec. 31, 2021						193,864,000